Femme et Homme
- | Pays : -
- | Organes : -
- | Spécialités : -
Extrait
To determine the effect of Rimonabant 20mg on the co-primary endpoint including Fasting Plasma Glucose (FPG), HDL-Cholesterol (HDL-C) and triglyceride (TG) levels over a period of 12 months when prescribed with a mild hypocaloric diet in abdominally obese patients with impaired fasting blood glucose and with or without associated comorbidities.
Critère d'inclusion
- abdominally obese patients with impaired fasting blood glucose with or without other comorbidities